Smith Robert Joseph 4
4 · Citius Pharmaceuticals, Inc. · Filed Nov 12, 2024
Insider Transaction Report
Form 4
Smith Robert Joseph
Director
Transactions
- Award
Stock Option (Right to Purchase Common Stock)
2024-11-07+125,000→ 125,000 totalExercise: $0.38Exp: 2034-11-07→ Common Stock (125,000 underlying)
Holdings
- 75,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.69Exp: 2034-03-12→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
- [F2]The options are vested in full and exercisable immediately.